APA (7th ed.) Citation

Hillemanns, P., Denecke, A., Woelber, L., Böhmer, G., Jentschke, M., Schjetne, K. W., . . . Fredriksen, A. B. (2022). A Therapeutic Antigen-Presenting Cell-Targeting DNA Vaccine VB10.16 in HPV16-Positive High-Grade Cervical Intraepithelial Neoplasia: Results from a Phase I/IIa Trial. Clinical cancer research, 28(22), 4885-4892. https://doi.org/10.1158/1078-0432.CCR-22-1927

Chicago Style (17th ed.) Citation

Hillemanns, Peter, Agnieszka Denecke, Linn Woelber, Gerd Böhmer, Matthias Jentschke, Karoline W. Schjetne, Karsten M.H Bruins Slot, and Agnete B. Fredriksen. "A Therapeutic Antigen-Presenting Cell-Targeting DNA Vaccine VB10.16 in HPV16-Positive High-Grade Cervical Intraepithelial Neoplasia: Results from a Phase I/IIa Trial." Clinical Cancer Research 28, no. 22 (2022): 4885-4892. https://doi.org/10.1158/1078-0432.CCR-22-1927.

MLA (9th ed.) Citation

Hillemanns, Peter, et al. "A Therapeutic Antigen-Presenting Cell-Targeting DNA Vaccine VB10.16 in HPV16-Positive High-Grade Cervical Intraepithelial Neoplasia: Results from a Phase I/IIa Trial." Clinical Cancer Research, vol. 28, no. 22, 2022, pp. 4885-4892, https://doi.org/10.1158/1078-0432.CCR-22-1927.